Detalhe da pesquisa
1.
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer.
Cell
; 184(25): 6119-6137.e26, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890551
2.
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.
Cell
; 181(2): 236-249, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32302568
3.
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
Cell
; 175(4): 984-997.e24, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30388455
4.
Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide.
CA Cancer J Clin
; 73(4): 358-375, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36859638
5.
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.
Cell
; 150(6): 1107-20, 2012 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22980975
6.
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.
Future Oncol
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357801
7.
State legislative trends related to biomarker testing.
Cancer
; 128(15): 2865-2870, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35607821
8.
Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design.
Future Oncol
; 18(7): 781-791, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34918546
9.
From clinical specimens to human cancer preclinical models-a journey the NCI-cell line database-25 years later.
J Cell Biochem
; 121(8-9): 3986-3999, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31803961
10.
M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
Oncologist
; 24(8): e749-e754, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30696724
11.
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial.
Lancet Oncol
; 18(10): 1307-1316, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28919011
12.
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.
Cancer
; 123(21): 4099-4105, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28743157
13.
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
Lancet Oncol
; 17(7): 984-993, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283860
14.
Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial.
Lancet Oncol
; 17(5): 642-50, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27080216
15.
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
Cancer
; 122(5): 766-72, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26695526
16.
Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer.
Cancer
; 121(15): 2570-7, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25876525
17.
Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
Cancer
; 121(3): 448-56, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25273224
18.
Review: Thyroid hormone therapy does not improve QoL or symptoms in subclinical hypothyroidism.
Ann Intern Med
; 170(4): JC17, 2019 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30776806
19.
Divide and Conquer to Treat Lung Cancer.
N Engl J Med
; 375(19): 1892-1893, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27718875
20.
State of the art: Response assessment in lung cancer in the era of genomic medicine.
Radiology
; 271(1): 6-27, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24661292